Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/50579
DC FieldValueLanguage
dc.contributor.authorGonzález, Antonio G.en_US
dc.contributor.authorHernández Silva, Margaritaen_US
dc.contributor.authorPadrón, Juan I.en_US
dc.contributor.authorLeón, Franciscoen_US
dc.contributor.authorReyes, Eduardoen_US
dc.contributor.authorÁlvarez-Mon, Melchoren_US
dc.contributor.authorPivel, Juan P.en_US
dc.contributor.authorQuintana Aguiar, José Martínen_US
dc.contributor.authorEstévez, Franciscoen_US
dc.contributor.authorBermejo, Jaimeen_US
dc.contributor.otherQuintana, Jose-
dc.contributor.otherPadron, Juan-
dc.contributor.otherEstevez, Francisco-
dc.contributor.otherLeon, Francisco-
dc.date.accessioned2018-11-24T17:09:01Z-
dc.date.available2018-11-24T17:09:01Z-
dc.date.issued2002en_US
dc.identifier.issn0022-2623en_US
dc.identifier.urihttp://hdl.handle.net/10553/50579-
dc.description.abstractThe biological activity of compound 9 obtained by introducing an α-methylene-γ-butyrolactone group into 3-(4-hydroxyphenyl)propionic acid, 1, was studied for possible effects on HL-60 cells, murine splenocytes, and human peripheral mononuclear cells (PBMC). 9 induced apoptosis in the HL-60 cell line and has a clear capacity to inhibit proliferation induced in murine splenocytes and PBMC by different mitogenic agents with no apparent toxic side effects. 9 was synthesized from 1, and its structure and stereochemistry were elucidated by spectroscopic methods.en_US
dc.languageengen_US
dc.relation.ispartofJournal of Medicinal Chemistryen_US
dc.sourceJournal Of Medicinal Chemistry[ISSN 0022-2623],v. 45 (12), p. 2358-2361en_US
dc.subject32 Ciencias médicasen_US
dc.subject2302 Bioquímicaen_US
dc.subject.otherTumor Inhibitorsen_US
dc.subject.otherMyeloma Cellsen_US
dc.subject.otherPharmacokineticsen_US
dc.subject.otherInductionen_US
dc.subject.otherApoptosisen_US
dc.subject.otherInversionen_US
dc.subject.otherImexonen_US
dc.subject.otherGrowthen_US
dc.subject.otherDeathen_US
dc.titleSynthesis and antiproliferative activity of a new compound containing an α-methylene-γ-lactone groupen_US
dc.typeinfo:eu-repo/semantics/Articleen_US
dc.typeArticleen_US
dc.identifier.doi10.1021/jm025518nen_US
dc.identifier.scopus0037030646-
dc.identifier.isi000175957700004-
dcterms.isPartOfJournal Of Medicinal Chemistry-
dcterms.sourceJournal Of Medicinal Chemistry[ISSN 0022-2623],v. 45 (12), p. 2358-2361-
dc.contributor.authorscopusid56387707800-
dc.contributor.authorscopusid7403410250-
dc.contributor.authorscopusid7003856519-
dc.contributor.authorscopusid7005039451-
dc.contributor.authorscopusid35492897800-
dc.contributor.authorscopusid7004340382-
dc.contributor.authorscopusid6701382830-
dc.contributor.authorscopusid8681043500-
dc.contributor.authorscopusid7003810011-
dc.contributor.authorscopusid7101636723-
dc.description.lastpage2361en_US
dc.identifier.issue12-
dc.description.firstpage2358en_US
dc.relation.volume45en_US
dc.investigacionCiencias de la Saluden_US
dc.type2Artículoen_US
dc.identifier.wosWOS:000175957700004-
dc.contributor.daisngid914093-
dc.contributor.daisngid8582629-
dc.contributor.daisngid15692786-
dc.contributor.daisngid618078-
dc.contributor.daisngid136703-
dc.contributor.daisngid11720307-
dc.contributor.daisngid5697379-
dc.contributor.daisngid125745-
dc.contributor.daisngid905700-
dc.contributor.daisngid128315-
dc.contributor.daisngid384944-
dc.contributor.daisngid5695465-
dc.description.notasThis research was supported in part by FEDER Grant 1FD1997-1831 (J.B.B), in part by the Fondo de Investigaciones Sanitarias (FIS) Grant 00/0806 (M.A and E.R), and in part by Dirección General de Universidades e Investigación del Gobierno de Canarias Grant 1999/156 (F.E. and J.Q.). M.H.S. thanks the Universidad del Bio-Bio (Chile) for a predoctoral fellowship.en_US
dc.identifier.investigatorRIDK-5709-2014-
dc.identifier.investigatorRIDI-7660-2014-
dc.identifier.investigatorRIDK-5125-2014-
dc.identifier.investigatorRIDNo ID-
dc.description.numberofpages4en_US
dc.utils.revisionen_US
dc.contributor.wosstandardWOS:Gonzalez, AG-
dc.contributor.wosstandardWOS:Silva, MH-
dc.contributor.wosstandardWOS:Padron, JI-
dc.contributor.wosstandardWOS:Leon, F-
dc.contributor.wosstandardWOS:Reyes, E-
dc.contributor.wosstandardWOS:Alvarez-Mon, M-
dc.contributor.wosstandardWOS:Pivel, JP-
dc.contributor.wosstandardWOS:Quintana, J-
dc.contributor.wosstandardWOS:Estevez, F-
dc.contributor.wosstandardWOS:Bermejo, J-
dc.date.coverdateJunio 2002en_US
dc.identifier.ulpgcen_US
dc.contributor.buulpgcBU-MEDen_US
dc.description.jcr4,566-
dc.description.jcrqQ1-
dc.description.scieSCIE-
item.fulltextSin texto completo-
item.grantfulltextnone-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0001-8225-4538-
crisitem.author.orcid0000-0002-9728-2774-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameQuintana Aguiar, José Martín-
crisitem.author.fullNameEstévez Rosas, Francisco Jesús-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

52
checked on Apr 21, 2024

WEB OF SCIENCETM
Citations

47
checked on Feb 25, 2024

Page view(s)

53
checked on Nov 18, 2023

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.